Used in research to inhibit the interaction between the EWS-FLI1 fusion protein and RNA helicase A, which is implicated in Ewing sarcoma. Shows potential as a targeted therapy for cancers driven by ETS family transcription factors, particularly in preclinical models of Ewing sarcoma. Demonstrates anti-tumor activity by inducing apoptosis and reducing cancer cell proliferation. Also serves as a tool compound for studying oncoprotein interactions and small molecule inhibition in transcription factor-driven malignancies.